Literature DB >> 18991114

A mixture model approach in gene-gene and gene-environmental interactions for binary phenotypes.

Lang Li1, Menggang Yu, Robarge D Jason, Changyu Shen, Faouzi Azzouz, Howard L McLeod, Silvana Borges-Gonzales, Anne Nguyen, Todd Skaar, Zeruesenay Desta, Christopher J Sweeney, David A Flockhart.   

Abstract

In translational research, a genetic association study of a binary outcome has a twofold aim: test whether genetic/environmental variables or their combinations are associated with a clinical phenotype, and determine how those combinations are grouped to predict the phenotype (i.e., which combinations have a similarly distributed phenotype, and which ones have differently distributed phenotypes). The second part of this aim has high clinical appeal, because it can directly facilitate clinical decisions. Although traditional logistic regression can detect gene-gene or gene-environmental interaction effects on binary phenotypes, they cannot decisively determine how genotype combinations are grouped to predict the phenotype. Our proposed mixture model approach is valuable in this context. It concurrently detects main and interaction effects of genetic and environmental variables through a likelihood ratio test (LRT) and conducts phenotype cluster analysis based on genetic and environmental variable combinations. The theoretical distribution of the proposed mixture model's likelihood ratio test is robust not only to small sample size but also to unequal sample size in various genotype and environmental subgroups. Hypothesis testing through a likelihood ratio test results in a fast algorithm for p-value calculations. Extensive simulation studies demonstrate that mixture model, overall test in logistic regression, and Monte Carlo based logic regression constantly possess the best power to detect multi-way gene/environmental combinations. The mixture model approach has the highest recovery probability to recover the true partition in the simulation studies. Its applications are exemplified in interim data analyses for two cancer studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991114      PMCID: PMC2790052          DOI: 10.1080/10543400802369038

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  11 in total

1.  Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway.

Authors:  S Kahlert; S Nuedling; M van Eickels; H Vetter; R Meyer; C Grohe
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

2.  Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity.

Authors:  Marylyn D Ritchie; Lance W Hahn; Jason H Moore
Journal:  Genet Epidemiol       Date:  2003-02       Impact factor: 2.135

Review 3.  New strategies for identifying gene-gene interactions in hypertension.

Authors:  Jason H Moore; Scott M Williams
Journal:  Ann Med       Date:  2002       Impact factor: 4.709

4.  Identifying interacting SNPs using Monte Carlo logic regression.

Authors:  Charles Kooperberg; Ingo Ruczinski
Journal:  Genet Epidemiol       Date:  2005-02       Impact factor: 2.135

5.  Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment.

Authors:  Silvana Borges; Zeruesenay Desta; Lang Li; Todd C Skaar; Bryan A Ward; Anne Nguyen; Yan Jin; Anna Maria Storniolo; D Michele Nikoloff; Lin Wu; Grant Hillman; Daniel F Hayes; Vered Stearns; David A Flockhart
Journal:  Clin Pharmacol Ther       Date:  2006-07       Impact factor: 6.875

Review 6.  Mixture distributions in human genetics research.

Authors:  N J Schork; D B Allison; B Thiel
Journal:  Stat Methods Med Res       Date:  1996-06       Impact factor: 3.021

7.  Association between the CYP3A5 genotype and blood pressure.

Authors:  Herbert Ho; Amar Pinto; Stephen D Hall; David A Flockhart; Lang Li; Todd C Skaar; Peter Cadman; Daniel T O'Connor; Urban Wagner; Naomi S Fineberg; Myron H Weinberger
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

8.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.

Authors:  M D Ritchie; L W Hahn; N Roodi; L R Bailey; W D Dupont; F F Parl; J H Moore
Journal:  Am J Hum Genet       Date:  2001-06-11       Impact factor: 11.025

9.  CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment.

Authors:  Yan Jin; Zeruesenay Desta; Vered Stearns; Bryan Ward; Herbert Ho; Kyung-Hoon Lee; Todd Skaar; Anna Maria Storniolo; Lang Li; Adjei Araba; Rebecca Blanchard; Anne Nguyen; Lynda Ullmer; Jill Hayden; Suzanne Lemler; Richard M Weinshilboum; James M Rae; Daniel F Hayes; David A Flockhart
Journal:  J Natl Cancer Inst       Date:  2005-01-05       Impact factor: 13.506

10.  Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.

Authors:  M Desai; J E Tanus-Santos; L Li; J C Gorski; M Arefayene; Y Liu; Z Desta; D A Flockhart
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

View more
  3 in total

1.  Cuckoo search epistasis: a new method for exploring significant genetic interactions.

Authors:  M Aflakparast; H Salimi; A Gerami; M-P Dubé; S Visweswaran; A Masoudi-Nejad
Journal:  Heredity (Edinb)       Date:  2014-02-19       Impact factor: 3.821

2.  Beyond the fourth wave of genome-wide obesity association studies.

Authors:  C H Sandholt; T Hansen; O Pedersen
Journal:  Nutr Diabetes       Date:  2012-07-30       Impact factor: 5.097

3.  Medication adherence and tolerability of Alzheimer's disease medications: study protocol for a randomized controlled trial.

Authors:  Noll L Campbell; Paul Dexter; Anthony J Perkins; Sujuan Gao; Lang Li; Todd C Skaar; Amie Frame; Hugh C Hendrie; Chris M Callahan; Malaz A Boustani
Journal:  Trials       Date:  2013-05-04       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.